Palbociclib Combine With Anti-HER2 Therapy in Triple Positive ABC

Clinical trial NCT05969184 · COMPLETED

Trial details

NCT number: NCT05969184
Sponsor: Peking University Cancer Hospital & Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasm Female

Start date: 2021-12-12
Primary completion: 2026-04-25
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.